Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2026-01-03 @ 7:19 PM
Study NCT ID:
NCT00674635
Status:
COMPLETED
Last Update Posted:
2016-12-01
First Post:
2008-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2010-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-22
First Submit QC Date:
None
Study First Post Date:
2008-05-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-03-28
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-11-30
Last Update Post Date:
2016-12-01
Last Update Post Date Type:
ESTIMATED